ArticleMolecular therapy. Advances2026

Advancing AADC deficiency therapy through MR-guided multisite delivery of AAV2-hAADC to dopaminergic and serotonergic pathways in the brainstem.

Lluis Samaranch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.